Computed ranking

Oral and needle-free GLP-1 options

What is actually available without injections, separated into approved products and compounded preparations whose absorption is unestablished. Recomputed at every build from the published dataset; nothing on this page is a hand-assigned placement.

How to read this

1. Henry Meds

Henry Meds publishes no tirzepatide price at any dose on our basis. Henry Meds sells compounded semaglutide by injection at $297 per month, checkout-verified, and does not sell injectable tirzepatide at all — its tirzepatide is an oral dissolving tablet sold only as a $1,047 three-month

2. Hims & Hers

Hims & Hers charges a flat $453 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated. After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound

3. NovoCare Pharmacy (Wegovy)

NovoCare Pharmacy (Wegovy) charges a flat $349 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses ($399 for the 7.2 mg HD pen), with a $199 introductory price on the first two starter-dose fills and oral Wegovy tabl

4. Direct Meds

Direct Meds prices tirzepatide by dose: $299 per month at 2.5 mg rising to $399 at 10 mg, a difference of $100 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated. Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on

5. Direct Meds

Direct Meds prices semaglutide by dose: $249 per month at 0.25 mg rising to $297 at 2.4 mg, a difference of $48 a month between the bottom and top of the ladder. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated. Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on

6. Strut Health

Strut Health charges a flat $199 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 10, 12.5, 15 mg, so those doses are left blank rather than estimated. Strut Health offers compounded GLP-1s in sublingual/oral and injectable formats, with the oral/sublingual semaglutide as the lowest entry point in the market at $99/mo. Injectable semaglutide starts at $149 and injectabl

7. Strut Health

Strut Health charges a flat $99 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7, 2.4 mg, so those doses are left blank rather than estimated. Strut Health offers compounded GLP-1s in sublingual/oral and injectable formats, with the oral/sublingual semaglutide as the lowest entry point in the market at $99/mo. Injectable semaglutide starts at $149 and injectabl

8. Synergy Rx

Synergy Rx charges a flat $349 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 10, 12.5, 15 mg, so those doses are left blank rather than estimated. Synergy Rx offers compounded GLP-1s in injectable and oral formats across all 50 states, with named pharmacies. Injectable semaglutide advertises from $199/mo with an active promotional banner; injectable tirzepatide fro

Questions

How is this ranking produced?

What is actually available without injections, separated into approved products and compounded preparations whose absorption is unestablished. It is a computation over the published dataset, run at build time. No provider can pay for a placement, because no placement is assigned by a person.

How current are these prices?

The dataset version is 2026-08-11 and each figure carries its own capture date on the provider's record page. Prices change; verify at the provider's checkout before paying.